Related Experiment Videos

The Brazilian Family Health Program and secondary stroke and myocardial infarction prevention: a 6-year cohort study

Norberto L Cabral1, Selma Franco, Alexandre Longo

  • 1Department of Medicine, University of Região de Joinville, Univille, Santa Catarina, Brazil. nlcabral@terra.com.br

Insights

Brazil's Family Health Program (FHP) significantly reduced deaths from secondary stroke and myocardial infarction compared to non-FHP care. This public health model demonstrates superior effectiveness in cardiovascular disease patient outcomes.

Area of Science:

  • Public Health
  • Cardiovascular Medicine
  • Health Services Research

Background:

  • Cardiovascular diseases, including stroke and myocardial infarction, represent a significant global health burden.
  • Effective healthcare models are crucial for managing chronic conditions and secondary prevention.
  • Brazil's Family Health Program (FHP) is a large-scale public healthcare initiative aiming to improve primary and secondary care access.

Purpose of the Study:

  • To compare the incidence of recurrent or fatal cardiovascular disease in patients managed by Brazil's Family Health Program (FHP) versus non-FHP care models.
  • To evaluate the effectiveness of the FHP in secondary prevention of stroke and myocardial infarction.

Main Methods:

  • A cohort study followed outpatients discharged after a first stroke from 2005 to 2010.
  • Data sources included public hospital records, death certificates, and outpatient monitoring.
  • Outcomes assessed were stroke recurrence, myocardial infarction, and all-cause mortality.

Main Results:

  • Patients in FHP care experienced a lower incidence of stroke or myocardial infarction (30.1%) compared to non-FHP care (36.2%).
  • Mortality rates were significantly lower in the FHP group (37.9%) versus non-FHP (54.3%).
  • FHP use was associated with a 42% lower hazard of death from all causes (HR=0.58), with an absolute risk reduction of 16.4%.

Conclusions:

  • Family Health Program (FHP) care is more effective than non-FHP care in preventing death following secondary stroke and myocardial infarction.
  • The FHP model demonstrates significant public health benefits in reducing cardiovascular mortality.
  • Findings support the expansion and strengthening of the FHP for improved patient outcomes.
Abstract

Related Concept Videos

Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
Hemorrhagic Stroke l: Introduction01:17

Hemorrhagic Stroke l: Introduction

A hemorrhagic stroke is an acute neurological event that occurs when a weakened cerebral blood vessel ruptures, allowing blood to accumulate within or around the brain. The sudden release of blood forms a focal hematoma that increases intracranial pressure, displaces neural tissue, and can obstruct cerebrospinal fluid pathways. These effects may be compounded by intraventricular extension of the hemorrhage, cerebral edema, or compression of adjacent structures, all of which contribute to...
Ischemic Stroke l: Introduction01:15

Ischemic Stroke l: Introduction

Ischemic stroke is an acute cerebrovascular condition in which blood flow to a brain region is suddenly interrupted, leading to tissue infarction. Neurons depend on continuous oxygen and glucose supply, so even brief reductions in perfusion cause energy failure, ionic imbalance, and irreversible injury. Ischemic strokes are classified into thrombotic and embolic types based on their underlying mechanisms.Thrombotic MechanismsThrombotic stroke develops when a clot forms within a cerebral artery.
Blood Studies for Cardiovascular System I: Cardiac Biomarkers01:20

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
Ischemic Heart Disease: Overview01:17

Ischemic Heart Disease: Overview

Ischemic heart disease occurs when the heart's blood supply dwindles, causing an ominous lack of oxygen and nutrients. This deficiency, stemming from reduced or obstructed blood flow, spells danger, leading to heart muscle damage and dysfunction.
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and narrowing...